China has officially added drugs from three major pharmaceutical companies—Eli Lilly, Pfizer, and Johnson & Johnson—to its inaugural innovative drug catalog for private insurance. This list...
Eli Lilly, Pfizer, and Johnson & Johnson have been included in China’s first innovative drug catalog for private insurance. This significant development features 19 high-cost medications...
Wall Street experienced significant declines on September 29, 2023, following U.S. President Donald Trump‘s announcement of potential tariff increases on imports from China. Trump characterized China’s...
Johnson & Johnson (NYSE: JNJ) has announced the withdrawal of its LINX Reflux Management System from markets outside the United States, effective in March 2024. This...
